Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastric and esophageal mucosal surface is the innermost tissue layer of the upper gastrointestinal tract, serving as a vital physiological barrier against aggressive luminal factors such as hydrochloric acid, pepsin, and bile salts (StatPearls, 2023). This surface is characterized by a complex defense system including a mucus-bicarbonate layer, tight junctions between epithelial cells, and a rich submucosal blood flow that facilitates rapid cellular repair (NCBI, 2022). In the esophagus, the mucosa is primarily composed of stratified squamous epithelium for mechanical durability, whereas the gastric mucosa is specialized for secretion and acid resistance (PubMed, 2021). Impairment of this mucosal integrity is a primary driver in the development of erosive esophagitis, peptic ulcers, and chronic inflammatory states like gastritis (NIH, 2023). While not a single molecular target like a receptor or enzyme, it is the site of action for cytoprotective agents and mucosal adherents that reinforce the barrier to promote healing and prevent further injury (PubChem, 2024).
Drugs interacting with this surface typically function by forming a physical protective layer (polymeric film), neutralizing luminal acid, or stimulating the secretion of endogenous cytoprotective factors such as mucus, bicarbonate, and prostaglandins (StatPearls, 2023; PubChem, 2024).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric and esophageal mucosal surface.